Larkspur Biosciences reveals new TIM-1 program for cancer
June 26, 2023
Larkspur Biosciences Inc. recently published findings uncovering a role for B cells in antitumor immunity, and highlighting TIM-1 as a targetable checkpoint protein central to B-cell antitumor activity.